Table 2.

Drug Survival Rate at 12 Week, 24 Week and 52 Week

	Ixekizumab (n=70)			Secukinumab (n=175)			Guselkumab (n=36)			Adalimumab (n=105)
	Estimate	SE	n	Estimate	SE	n	Estimate	SE	n	Estimate	SE	n
12 week	0.886	0.038	62	0.92	0.021	162	0.972	0.027	36	0.733	0.043	76
24 week	0.814	0.046	57	0.88	0.025	155	0.861	0.058	31	0.59	0.048	61
52 week	0.671	0.056	47	0.63	0.037	102	0.722	0.075	24	0.371	0.047	39

Abbreviation: SE, standard error.